ArticleJournal of immunotherapy and precision oncology2025

Exceptional Response in a Patient with mRCC Through Precision-Guided Treatment Involving Immunotherapy Rechallenge with Temsirolimus and Bevacizumab.

Ashkan Adibi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.